AK Registry

Have You Been Told by Your Doctor That You Have Actinic Keratoses or Moles?

Who is conducting the study?

The Skin Cancer Institute and Skin Cancer Prevention Program at the University of Arizona Cancer Center.

An Institutional Review Board responsible for human subjects research at The University of Arizona reviewed this research project and found it to be acceptable, according to applicable state and federal regulations and University policies designed to protect the rights and welfare of participants in research.

What is the purpose of the study?

The purpose of this study is to create a Biorepository or a sample repository (tissue bank) for future research to better understand the biology and treatment of skin cancer.  This research will be based on the personal health information of the study participants, their medical and treatment history for skin cancer or pre-cancerous skin lesions and moles, and the collection of their tissue, blood, and saliva samples which will be stored and then used for laboratory tests.

How long is the study?

Each participant will come to the research clinic for 3 study visits lasting up to a month.

Who is eligible for the study? 

Men and women, age 18 and older, who:

  • Have pre-cancerous lesions (Actinic Keratoses).
  • Have not had any skin cancer on the right arm within 3 months prior to evaluation.
  • Have not used topical prescription or over-the-counter medications other than sunscreens and emollients in the past 30 days.
  • Have not had invasive cancer or chemotherapy in the past 5 years.
  • Meet other eligibility requirements.

What is required during the study?

Study participants are asked to complete questionnaires to answer questions about their demographics, medical history, and skin cancer history. A total of 4 – 6 small skin samples (punch or shave biopsies) are collected from each participant as well as a small amount of blood and saliva (approximately 2 tablespoons).

 

Qualified volunteers receive compensation for their participation in the study.

The Study Coordinator will be happy to discuss the study with you. 

Please call:

520-321-7747